---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-028500"
form_type: "8-K"
ticker: "CTOR"
cik: "0001851484"
company_name: "CITIUS ONCOLOGY, INC."
filed_at: "2024-07-19T23:59:59+00:00"
generated_at: "2026-05-31T19:11:07.934431+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# TenX Keane Acquisition extends business combination deadline to August 18, 2024 via $66,667 note from Citius Pharma

## Summary
- Citius Pharma deposited $66,667 into trust to extend deadline from July 18 to August 18, 2024; fourth monthly extension.
- Prior extensions occurred on April 26, May 17, and June 17, 2024; Company can extend up to November 18, 2024.
- Promissory note is unsecured, bears no interest, and is repayable only upon closing if trust balance >= $2M.
- Extension funded under Merger Agreement; Note is evidenced by Exhibit 10.4 to this 8-K.

## SEC filing metadata
- accession: 0001493152-24-028500
- form_type: 8-K
- ticker: CTOR
- cik: 0001851484
- company_name: CITIUS ONCOLOGY, INC.
- filed_at: 2024-07-19T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1851484/000149315224028500/0001493152-24-028500-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1851484/000149315224028500/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-028500
- JSON: https://secwatch.observer/filing/0001493152-24-028500.json
- Plain text: https://secwatch.observer/filing/0001493152-24-028500.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.